10th Jun 2009 07:00
|
For immediate release |
10 June 2009 |
ABCAM PLC
("Abcam" or "the Company")
Change of Registered Office
Cambridge UK, 10 June 2009: Abcam plc, the rapidly growing bioscience company that markets antibodies via its own online catalogue, announces that the address of its registered and head office has changed to:
330 Cambridge Science Park, Milton Road, Cambridge CB4 0FL, UK.
Jonathan Milner, Abcam's Chief Executive Officer, commented: "Our move to larger premises on the Cambridge Science Park gives us the capacity to continue to deliver our strategy, which is focused on continued strong growth. The new premises comprise 25,000 sq ft of space under a flexible 10-year lease for our sales teams, administration and warehousing and are located close to our production facility."
For further information please contact:
|
Abcam |
+ 44 (0) 1223 696000 |
|
Jonathan Milner, Chief Executive Officer |
|
|
Jeffrey Iliffe, Chief Financial Officer www.abcam.com |
|
|
Numis Securities |
+ 44 (0) 20 7260 1000 |
|
Michael Meade / Nick Westlake - Nominated Adviser |
|
|
James Black - Corporate Broking |
|
|
Buchanan Communications |
+ 44 (0) 20 7466 5000 |
|
Mark Court / Mary-Jane Johnson / Stasa Filiplic |
Notes for editors:
About Abcam plc
Abcam is a producer and distributor of research-grade antibodies headquartered in Cambridge, UK, with a US office located in Cambridge, Massachusetts and a Japanese office in Tokyo. Abcam was admitted to AIM in November 2005 and trades under the ticker symbol ABC. The Company produces and distributes its own and third party produced antibodies to academic and commercial users throughout the world with product information provided and ordering available through the Company's website, www.abcam.com. The antibodies are sold under the Abcam brand name. The Company's vision is to build the largest online antibody resource in the world while also ensuring that the antibodies are of high quality and commercially viable. Abcam now has an online catalogue of over 52,000 products, most of which are antibodies, from over 250 suppliers supported by up-to-date and detailed technical data sheets, which are created by the Company. The Company currently employs 228 staff in its three operating companies.
Related Shares:
ABC.L